About The ASCO Post
Rights and Permissions
In the Clinic
View By Issue
ELCC 2019: European Lung Cancer Congress
AACR Annual Meeting 2019
NCCN Annual Conference 2019
2019 SGO Annual Meeting on Womens Cancer
2019 Multidisciplinary Thoracic Cancers Symposium
Biomarkers in Immunotherapy
IMPROVING NSCLC OUTCOMES
Methotrexate–Induced Kidney Injury
No results found for "Muhamed Baljevic, MD and Sarah A. Holstein, MD, PhD"
Ensure words are spelled correctly.
Try rephrasing keywords or using synonyms.
Try less specific keywords.
Today In Oncology
Does Intake of Dietary Fat Increase Risk of Skin Cancer?
FDA Approves Pembrolizumab Plus Axitinib for First-Line Treatment of Advanced Renal Cell Carcinoma
Cervical Cancer Subtype Rising in Some Populations
Deep-Learning Model May Improve Predictions of Survival and Specific Outcomes in Lung Cancer
KEYNOTE-042: Pembrolizumab vs Chemotherapy in Previously Untreated Locally Advanced or Metastatic NSCLC With PD-L1 Expression ≥ 1%
Most Read Stories
Treatment of Patients With Imminently Fatal de Novo Metastatic Cancer
Follow-up of Adjuvant Paclitaxel and Trastuzumab in Small HER2-Positive Breast Tumors
FDA Pipeline: Designations for Myelodysplastic Syndromes, Triple-Negative Breast Cancer, AML, and EBV-Associated Cancers
'Oral Cryotherapy' for Patients Undergoing Oxaliplatin-Based Chemotherapy
Addition of Radiotherapy After Breast-Conserving Surgery Based on Level of Tumor-Infiltrating Lymphocytes
© 2019 HSP News Service, L.L.C.